Authors:
ZITTOUN R
SUCIU S
MANDELLI F
DEWITTE T
THALER J
STRYCKMANS P
HAYAT M
PEETERMANS M
CADIOU M
SOLBU G
PETTI MC
WILLEMZE R
Citation: R. Zittoun et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASSOCIATED WITH INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A RANDOMIZED TRIAL BY THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LEUKEMIA COOPERATIVE GROUP, Journal of clinical oncology, 14(7), 1996, pp. 2150-2159
Authors:
KEATING S
SUCIU S
DEWITTE T
MANDELLI F
WILLEMZE R
RESEGOTTI L
BROCCIA G
THALER J
LABAR B
DAMASIO E
BIZZI B
ROTOLI B
VEKHOFF A
MUUS P
PETTI MC
DARDENNE M
SOLBU G
VEGNA ML
ZITTOUN R
Citation: S. Keating et al., PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) ALLOGRAFTED IN FIRST COMPLETE REMISSION - AN ANALYSIS OF THE EORTC-GIMEMA AML 8A TRIAL, Bone marrow transplantation, 17(6), 1996, pp. 993-1001
Citation: J. Thaler et W. Hilbe, COMPARATIVE-ANALYSIS OF 2 CONSECUTIVE PHASE-II STUDIES WITH IFN-ALPHAAND IFN-ALPHA-C IN UNTREATED CHRONIC-PHASE CML PATIENTS(ARA), Bone marrow transplantation, 17, 1996, pp. 25-28
Authors:
HEIMPEL H
ALLAN NC
BACCARANI M
GUILHOT F
HEHLMANN R
HOROWITZ M
KLUINNELEMANS J
SCHAEFER U
STORB R
THALER J
Citation: H. Heimpel et al., CURRENT CONTROVERSIES ON THE ROLE OF INTERFERON-ALPHA FOR THERAPY OF CHRONIC MYELOID-LEUKEMIA, Bone marrow transplantation, 17, 1996, pp. 39-39
Authors:
EISTERER W
NEYER U
HILBE W
DIEM G
OHLSCHLEGEL C
LUDESCHER C
THALER J
Citation: W. Eisterer et al., EFFECT OF CYCLOSPORINE-A IN A PATIENT WITH REFRACTORY NEPHROTIC SYNDROME-ASSOCIATED WITH B-CHRONIC LYMPHOCYTIC-LEUKEMIA, Nephron, 72(3), 1996, pp. 468-471
Authors:
FEND F
THALER J
HILBE W
GSCHWENDTNER A
GREDLER E
WEYRER K
HAUN M
GRUNEWALD K
Citation: F. Fend et al., DETECTION OF RESIDUAL DISEASE IN HAIRY-CELL LEUKEMIA (HCL) - COMPARISON OF IMMUNOHISTOCHEMISTRY, SOUTHERN BLOT ANALYSIS AND CDRIII-PCR, Laboratory investigation, 74(1), 1996, pp. 646-646
Authors:
EISTERER W
HILBE W
STAUDER R
BECHTER O
FEND F
THALER J
Citation: W. Eisterer et al., AN AGGRESSIVE SUBTYPE OF B-CLL IS CHARACTERIZED BY STRONG CD44 EXPRESSION AND LACK OF CD11C, British Journal of Haematology, 93(3), 1996, pp. 661-669
Authors:
SEPP N
WEYRER K
HAUN M
ZELGER B
THALER J
FABER V
FRITSCH P
GRUNEWALD K
Citation: N. Sepp et al., DIFFERENTIATION OF PRIMARY AND SECONDARY CUTANEOUS B-CELL LYMPHOMA BYSOUTHERN BLOT ANALYSIS, American journal of clinical pathology, 106(6), 1996, pp. 749-757
Authors:
EIBL B
GREITER E
GRUNEWALD K
GASTL G
WEYRER K
THALER J
AULITZKY W
HERRMANN F
RAPP U
HUBER C
Citation: B. Eibl et al., EXPRESSION OF C-FOS CORRELATES WITH IFN-ALPHA RESPONSIVENESS IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA, Cytokines and molecular therapy, 1(1), 1995, pp. 29-38
Authors:
KONWALINKA G
SCHIRMER M
HILBE W
FEND F
GEISEN F
KNOBLECHNER A
PETZER A
THALER J
Citation: G. Konwalinka et al., MINIMAL RESIDUAL DISEASE IN HAIRY-CELL LEUKEMIA AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE, Blood cells, molecules, & diseases, 21(2), 1995, pp. 142-151
Authors:
LUDESCHER C
SPITALER M
HOFMANN J
EISTERER W
HILBE W
THALER J
Citation: C. Ludescher et al., MRP, MDR1 EXPRESSION AND RHODAMINE-123 EFFLUX IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, European journal of cancer, 31A, 1995, pp. 129-129
Authors:
EISTERER W
HILBE W
FEND F
LUDESCHER C
FALK M
THALER J
Citation: W. Eisterer et al., IDENTIFICATION OF A FAVORABLE SUBGROUP OF PATIENTS WITH GENERALIZED IMMUNOCYTOMAS BY FOLLICULAR DENDRITIC CELLS, Leukemia, 9(2), 1995, pp. 254-259
Authors:
LUDESCHER C
EISTERER W
HILBE W
GOTWALD M
HOFMANN J
ZABERNIGG A
CIANFRIGLIA M
THALER J
Citation: C. Ludescher et al., LOW-FREQUENCY OF ACTIVITY OF P-GLYCOPROTEIN (P-170) IN ACUTE LYMPHOBLASTIC-LEUKEMIA COMPARED TO ACUTE MYELOID-LEUKEMIA, Leukemia, 9(2), 1995, pp. 350-356
Authors:
KARBAN R
ENGLISHLOEB G
WALKER MA
THALER J
Citation: R. Karban et al., ABUNDANCE OF PHYTOSEIID MITES ON VITIS SPECIES - EFFECTS OF LEAF HAIRS, DOMATIA, PREY ABUNDANCE AND PLANT PHYLOGENY, Experimental & applied acarology, 19(4), 1995, pp. 189-197
Authors:
LUDESCHER C
EISTERER W
HILBE W
HOFMANN J
THALER J
Citation: C. Ludescher et al., DECREASED POTENCY OF MDR-MODULATORS UNDER SERUM CONDITIONS DETERMINEDBY A FUNCTIONAL ASSAY, British Journal of Haematology, 91(3), 1995, pp. 652-657
Authors:
ZITTOUN R
SUCIU S
SOLBU G
WATSON M
MUUS P
MANDELLI F
STRYCKMANS P
PEETERMANS M
THALER J
WILLEMZE R
Citation: R. Zittoun et al., COMPARISON OF QUALITY-OF-LIFE (QOL) OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIAS (AML) IN LONG-TERM FIRST COMPLETE REMISSION (CR) AFTER BONE-MARROW TRANSPLANTATION (BMT) - ALLOGENEIC OR AUTOLOGOUS - OR INTENSIVE CHEMOTHERAPY CONSOLIDATION (ICC) - EORTC-GIMEMA AML 8A STUDY, Blood, 86(10), 1995, pp. 1718-1718
Authors:
ZABERNIGG A
HILBE W
REINISCH N
EISTERER W
THALER J
SPOTL L
KONWALINKA G
Citation: A. Zabernigg et al., NORMAL GRANULOCYTE FUNCTION BUT IMPAIRED MONOCYTE FUNCTION IN A PATIENT WITH APLASTIC-ANEMIA, Acta haematologica, 94(2), 1995, pp. 109-111
Citation: J. Thaler et al., INTERLEUKIN-6 IN MULTIPLE-MYELOMA - CORRELATION WITH DISEASE-ACTIVITYAND KI-67 PROLIFERATION INDEX, Leukemia & lymphoma, 12(3-4), 1994, pp. 265-271
Authors:
SCHIRMER M
HILBE W
GEISEN F
FEND F
KNOBLECHNER A
THALER J
ZILIAN U
PETZER A
KONWALINKA G
Citation: M. Schirmer et al., MONOCLONAL-ANTIBODY B-LY7 - DETECTION OF MINIMAL RESIDUAL DISEASE AFTER TREATMENT OF HAIRY-CELL LEUKEMIA WITH 2-CHLORODEOXY ADENOSINE, Experimental hematology, 22(8), 1994, pp. 798-798
Authors:
CIUFFREDA KJ
ALPERT M
BLACKSTONE T
FUDGE R
THALER J
Citation: Kj. Ciuffreda et al., PURSUIT EYE-MOVEMENTS IN CHRONIC-SCHIZOPHRENICS - RELATIONSHIP BETWEEN INCREASED SACCADES AND NEGATIVE SYMPTOMS, Ophthalmic & physiological optics, 14(1), 1994, pp. 79-81
Authors:
HILBE W
THALER J
EISTERER W
LUDESCHER C
NIEDERWIESER D
Citation: W. Hilbe et al., TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOGENOUS LEUKEMIA WITH ACLACINOMYCIN-A (ACA) AND ETOPOSIDE (VP-16), Leukemia research, 18(9), 1994, pp. 655-658